Values First Advisors »

Zentalis Pharmaceuticals shares owned by Values First Advisors

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Values First Advisors from 13F filings

Historical chart of Values First Advisors investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Values First Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Values First Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.1M 71k 15.76
2023-12-31 $728k 48k 15.15
2023-09-30 $821k 41k 20.06
2023-06-30 $862k 31k 28.21
2023-03-31 $131k 7.6k 17.20
2021-12-31 $214k 2.5k 84.19

More positions owned by Values First Advisors

Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Short Treas Bd (SHV)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Ensign (ENSG)
Monolithic Power Systems (MPWR)
Vaalco Energy Com New (EGY)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Cintas Corporation (CTAS)
Amphenol Corp Cl A (APH)
Ishares U S Etf Tr Blackrock Sh Dur (NEAR)
Synovus Finl Corp Com New (SNV)
National Retail Properties (NNN)

View all positions for Values First Advisors

Top funds holding Zentalis Pharmaceuticals

Eventide Asset Management
Vanguard Group
Citadel Advisors
T. Rowe Price Associates
Federated Investors
Decheng Capital
PRIMECAP Management Company
Dimensional Fund Advisors
Bank of America Corporation
Logos Global Management
5AM Venture Management
Caption Management
Charles Schwab Investment Management
Boxer Capital
Paradigm Biocapital Advisors

View all funds holding Zentalis Pharmaceuticals